GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Upper GI Tract/Wedge Pillow vs Evening PPI for Nocturnal Reflux: Neurogastro & Motility | Feb. 2026
30

Wedge Pillow vs Evening PPI for Nocturnal Reflux: Neurogastro & Motility | Feb. 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated February 1, 2026

Many patients continue to experience nocturnal heartburn or regurgitation despite taking a standard morning proton pump inhibitor (PPI). Current practice often escalates to a second (evening) PPI dose, while wedge pillows are recommended as a non-pharmacologic option—yet direct comparative evidence has been limited.

This randomized noninferiority trial enrolled patients with frequent nocturnal reflux symptoms despite at least four weeks of morning PPI therapy. Participants were randomized for four weeks to either (1) add a wedge pillow while continuing morning PPI, or (2) intensify to twice-daily PPI. Outcomes included nocturnal symptom burden (NGSSIQ), quality of life, sleep quality, daytime sleepiness, and objective reflux metrics using 24-hour pH-impedance monitoring. Pillow adherence was objectively tracked using a pressure-sensing timekeeper.

At four weeks, the wedge pillow strategy was non-inferior to twice-daily PPI for improving nocturnal reflux symptoms. Notably, sleep quality improved more with the wedge pillow. Objective reflux testing showed only limited differences between groups, suggesting that the symptomatic benefit may not be solely explained by measurable reductions in reflux episodes, and may involve improved sleep mechanics or arousal thresholds. Compliance and satisfaction with the pillow were high.

Clinical takeaway: For patients with persistent nocturnal reflux symptoms on morning PPI, adding a wedge pillow is a credible, low-risk alternative to escalating acid suppression—particularly when sleep disruption is a dominant complaint.

Related Q&A

31

Capsule Sponge Triage for Reflux

This large, single-center, prospective cohort study evaluated a non-endoscopic capsule sponge (CS) triage pathway for patients routinely referred with reflux symptoms over 4 years. The goal was to...

32

Metopimazine in Gastroparesis: Safe, Mixed Efficacy Signals- AJG Feb.2026

Gastroparesis is a chronic, debilitating disorder characterised by nausea, vomiting, early satiety, postprandial fullness, and abdominal pain. Current pharmacologic options are limited by modest efficacy and safety concerns,...

33

LPS vs LPRD: The San Diego Consensus Redefines LPR- AJG Feb.26

Introduction “Laryngopharyngeal reflux (LPR)” has become a catch-all label for chronic throat and upper airway complaints—cough, throat clearing, hoarseness, phlegm, throat pain—often without objective evidence of reflux. This...

34

Psychological Factors Shape Outcomes After Achalasia Treatment- Gastroenterology Feb.26

Introduction Achalasia is traditionally managed as a pure motility disorder, and treatment success is usually judged by technical outcomes—lower oesophageal sphincter (LES) disruption, improved emptying on timed barium...

35

Beyond Gastric Cancer: The True Burden of H. pylori- Gastroenterology Feb.26

Introduction Helicobacter pylori is universally recognised as a major cause of gastric cancer, and screen-and-treat strategies are often evaluated almost exclusively through this lens. However, H. pylori also...

36

Vonoprazan based dual therapy of H.Pylori infection - Front. Med.,2026

The study titled "Vonoprazan-based dual therapy for H. pylori eradication" published in Frontiers in Medicine in 2026 systematically evaluates the efficacy and safety of Vonoprazan-based high-dose dual therapy...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer